Stephen Squinto
Signal active
Chairman
Bio
Stephen Squinto is the Executive Partner at OrbiMed Advisors.
Location
New York, New York, United States, North America
Social
Primary Organization
LyfeBulb
Founded
2014
Investment
1
Lead investment
0
Exits
0
Employees
1-10
Industry
Health Care, Medical
Jobs history
5
Gennao Bio
Co-founder and CEO
Invalid date - Current
OrbiMed
Executive Partner
2019 - Current
Passage Bio
Acting Head of Research and Development
Invalid date - Current
LyfeBulb
Chairman
Invalid date - Current
Alexion Pharmaceuticals
Co-Founder; Exec VP & Head of R&D
1992 - 2015
Board and Advisor Roles
5
Enlaza Therapeutics
Board Member
Invalid date - Current
iECURE
Board of Directors
2021 - Current
Gennao Bio
Chairman of the board
Invalid date - Current
Gemini Therapeutics
Board Member
Invalid date - Current
Audentes Therapeutics
Member of the Board of Directors
Invalid date - Current
Invest in regions
Profile Resume
Stephen Squinto is the Chairman at LyfeBulb, based in New York, New York, United States, North America. With a background in Health Care, Stephen Squinto has a rich history of leadership and innovation. Stephen Squinto studied BS chemistry @ University OF Chicago. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
15
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Mar 16, 2021 | - | Post-IPO Equity - Chemomab | OrbiMed | 45.5M |
| May 10, 2021 | Gennao Bio | Series A - Gennao Bio | OrbiMed | 40.0M |
| Sep 09, 2021 | iECURE | Series A - iECURE | OrbiMed | 50.0M |
| Apr 30, 2024 | Enlaza Therapeutics | Series A - Enlaza Therapeutics | J.P. Morgan Asset Management | 100.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity